98824-26-1

Basic information

• Product Name: BETA-CGRP, HUMAN
• Synonyms: CALCITONIN GENE RELATED PEPTIDE HUMAN;CALCITONIN GENE RELATED PEPTIDE;CALCITONIN GENE-RELATED PEPTIDE-II, HUMAN;BETA-CALCITONIN GENE RELATED PEPTIDE HUMAN;BETA-CGRP, HUMAN;BETA-CALCITONIN GENE RELATED PEPTIDE;CGRP-II (HUMAN);CGRP HUMAN
• CAS NO: 98824-26-1
• Molecular Formula: C162H267N51O48S3
• Molecular Weight: 3793.36
• Product Categories: Peptide
• Mol File: 98824-26-1.mol
• Article Data: 0

Chemical Properties

• Appearance: Lyophilized solid
• Storage Temp.: −20°C
• Solubility: Soluble in 5% acetic acid.
• CAS DataBase Reference: BETA-CGRP, HUMAN(CAS DataBase Reference)
• NIST Chemistry Reference: BETA-CGRP, HUMAN(98824-26-1)
• EPA Substance Registry System: BETA-CGRP, HUMAN(98824-26-1)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 98824-26-1(Hazardous Substances Data)

Usage

Description

BETA-CGRP, HUMAN, also known as Calcitonin Gene Related Peptide II, is a member of the calcitonin gene family. It is a potent, long-lasting vasodilator that plays a crucial role in studying CGRP receptor specificity, function, and CGRP signaling. The expression of BETA-CGRP, HUMAN is essential for understanding its various applications and therapeutic potential.

Uses

Used in Pharmaceutical Research:
BETA-CGRP, HUMAN is used as a research tool for studying CGRP receptor specificity and function, as well as CGRP signaling. This helps in the development of targeted therapies and understanding the underlying mechanisms of various diseases.
Used in Cardiovascular Applications:
As a potent, long-lasting vasodilator, BETA-CGRP, HUMAN is used in the treatment of cardiovascular diseases, particularly those involving constriction of blood vessels. Its vasodilatory effects can help improve blood flow and reduce the risk of heart attacks and strokes.
Used in Endocrine Applications:
BETA-CGRP, HUMAN is used as a therapeutic agent for the treatment of endocrine disorders, particularly those involving pancreatic β-cells. Activation of CGRP receptors on pancreatic β-cells increases plasma levels of pancreatic enzymes, which can help regulate blood sugar levels and improve overall endocrine function.
Used in Drug Development:
BETA-CGRP, HUMAN is used in the development of new drugs targeting CGRP receptors. These drugs can potentially treat a variety of conditions, including migraines, hypertension, and other diseases related to the CGRP signaling pathway.